Sage Bionetworks and Celgene have launched a new Apple iPhone-based mobile study, Journey PRO, to learn more about the disease burden borne by people with chronic anemia due to beta-thalassemia, myelofibrosis and myelodysplastic syndromes. The Journey PRO study will ... Read more